Success Metrics

Clinical Success Rate
100.0%

Based on 5 completed trials

Completion Rate
100%(5/5)
Active Trials
4(18%)
Results Posted
0%(0 trials)

Phase Distribution

Ph phase_1
4
18%
Ph early_phase_1
2
9%
Ph not_applicable
15
68%

Phase Distribution

6

Early Stage

0

Mid Stage

0

Late Stage

Phase Distribution21 total trials
Early Phase 1First-in-human
2(9.5%)
Phase 1Safety & dosage
4(19.0%)
N/ANon-phased studies
15(71.4%)

Highest Phase Reached

Phase 1

Trial Status & Enrollment

Completion Rate

71.4%

5 of 7 finished

Non-Completion Rate

28.6%

2 ended early

Currently Active

4

trials recruiting

Total Trials

22

all time

Status Distribution
Active(6)
Completed(5)
Terminated(2)
Other(9)

Detailed Status

unknown9
Completed5
Recruiting3
Withdrawn2
Active, not recruiting1
Enrolling by invitation1

Development Timeline

Analytics

Development Status

Total Trials
22
Active
4
Success Rate
100.0%
Most Advanced
Early Phase 1

Trials by Phase

Early Phase 12 (9.5%)
Phase 14 (19.0%)
N/A15 (71.4%)

Trials by Status

active_not_recruiting15%
recruiting314%
withdrawn29%
enrolling_by_invitation15%
not_yet_recruiting15%
unknown941%
completed523%

Recent Activity

Clinical Trials (22)

Showing 20 of 22 trialsScroll for more
NCT05228964Not Applicable

Focused Ultrasound Amygdala Neuromodulation

Completed
NCT07226648Not Applicable

Ultrasonic Neuromodulation of Cingulate Cortex for Fibromyalgia

Recruiting
NCT07389447Not Applicable

Focused Ultrasound Stimulation of the Cerebellum to Induce Changes in Cognition and Brain Activity

Active Not Recruiting
NCT03868293Not Applicable

Low Intensity Focused Ultrasound Epilepsy: A Pilot Trial

Recruiting
NCT04796220Phase 1

Focused Ultrasound and Gemcitabine in Breast Cancer

Recruiting
NCT06376955Not Applicable

High Intensity Interval Versus Focused Ultrasound on Insulin Resistance in Diabetics With Abdominal Obesity

Not Yet Recruiting
NCT03156335Not Applicable

Trial of MR-guided Focused Ultrasound (MRgFUS) Bilateral Capsulotomy for the Treatment of Refractory Obsessive-compulsive Disorder (OCD)

Completed
NCT05879692Not Applicable

Response of Irritable Bowel Syndrome to Abdominal Fat Reduction

Unknown
NCT04852367Phase 1

PanDox: Targeted Doxorubicin in Pancreatic Tumours

Withdrawn
NCT04063514Not Applicable

The Use of Focused Ultrasound and DCE K-trans Imaging to Evaluate Permeability of the Blood-Brain Barrier

Enrolling By Invitation
NCT05475340Early Phase 1

Open Label Study for the Use of Transcranial Ultrasound Treatment of Tremor

Unknown
NCT03477019Phase 1

Ultrasound-enhanced Delivery of Chemotherapy to Patients With Liver Metastasis From Breast- and Colorectal Cancer

Completed
NCT04775875Not Applicable

The Use of Transcranial Ultrasound Treatment of Obsessive-Compulsive Disorder

Unknown
NCT04770350Early Phase 1

Open Label Study for the Use of Transcranial Ultrasound for Treatment of Age-Related Frailty

Unknown
NCT04485208Not Applicable

Focused Ultrasound for the Treatment of Neuropathic Pain

Unknown
NCT05142397

The Dynamic Process of VMB and Mucosal Immunity After FUS Treatment of CIN Patients With Fertility Requirement

Unknown
NCT04192149Not Applicable

The Effects of Ultrasound on Central Nervous System

Unknown
NCT04168086Not Applicable

Cerebellar Functions in Visuomotor Adaptation

Unknown
NCT03882931Not Applicable

Functional Roles of Dorsolateral Prefrontal Cortex

Unknown
NCT03634631Not Applicable

Effects of Transcranial Focused Ultrasound on Human Primary Motor Cortex Using 7T fMRI

Completed

Drug Details

Intervention Type
DEVICE
Total Trials
22